首页> 外文OA文献 >Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase-4 (DPP-4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol-3 Kinase δ (PI3Kδ) inhibitors
【2h】

Design and elaboration of a tractable tricyclic scaffold to synthesize druglike inhibitors of dipeptidyl peptidase-4 (DPP-4), antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and highly potent and selective phosphoinositol-3 Kinase δ (PI3Kδ) inhibitors

机译:设计和制造易于处理的三环支架,以合成二肽基肽酶-4(DPP-4)的药物样抑制剂,CC趋化因子受体5的拮抗剂(CCR5)以及高效且选择性的磷酸肌醇-3激酶δ(PI3Kδ)。抑制剂

摘要

A novel molecular scaffold has been synthesized, and its incorporation into new analogues of biologically active molecules across multiple target classes will be discussed. In these studies, we have shown use of the tricyclic scaffold to synthesize potent inhibitors of the serine peptidase DPP-4, antagonists of the CCR5 receptor, and highly potent and selective PI3K δ isoform inhibitors. We also describe the predicted physicochemical properties of the resulting inhibitors and conclude that the tractable molecular scaffold could have potential application in future drug discovery programs.
机译:已经合成了新型分子支架,并将讨论其如何结合到跨多个靶类别的生物活性分子的新类似物中。在这些研究中,我们显示了使用三环支架合成丝氨酸肽酶DPP-4的有效抑制剂,CCR5受体的拮抗剂以及高效且选择性的PI3Kδ同工型抑制剂。我们还描述了所得抑制剂的预测理化性质,并得出结论,该易处理的分子支架可能在未来的药物开发计划中具有潜在的应用。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号